Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 17102-63-5 | MDL No. : | MFCD07369762 |
Formula : | C8H9BrO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HBEIHPSICGGZIF-UHFFFAOYSA-N |
M.W : | 217.06 | Pubchem ID : | 15128243 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.25 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 46.76 |
TPSA : | 29.46 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.42 cm/s |
Log Po/w (iLOGP) : | 2.28 |
Log Po/w (XLOGP3) : | 1.7 |
Log Po/w (WLOGP) : | 1.8 |
Log Po/w (MLOGP) : | 1.95 |
Log Po/w (SILICOS-IT) : | 2.34 |
Consensus Log Po/w : | 2.01 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.53 |
Solubility : | 0.643 mg/ml ; 0.00296 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.93 |
Solubility : | 2.53 mg/ml ; 0.0116 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.21 |
Solubility : | 0.133 mg/ml ; 0.000611 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.42 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
94% | With lithium borohydride In tetrahydrofuran at 60℃; for 16 h; Inert atmosphere | To a solution of methyl 4-bromo-2-methoxybenzoate (7.14g, 29mmol) in THF (35mL) was added a 2M solution of LiBH4 in THF (35mL, 70mmol, 2.4equiv). The solution was heated at 60°C for 16h. The reaction was then cooled to room temperature, and the solvent was removed under vacuum. The residue was stirred in a 5percent aqueous acetic acid solution (pH 6) for 15min. The aqueous layer was extracted with EtOAc (2×50mL), then the combined organic extracts were washed with brine, dried (MgSO4), filtered, and concentrated to yield the crude product as a tan oil. The oil was purified by flash chromatography using 5percent EtOAc in hexanes to provide 5.96g (94percent) of the product as a white solid: Rf 0.30 (10percent EtOAc/hexane); 1H NMR (CDCl3) δ 7.30 (d, 1H), 7.14 (d, 1H), 7.11 (s, 1H), 5.09 (t, 1H), 4.42 (d, 2H,), 3.77 (s, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
71% | Stage #1: With oxalyl dichloride; dimethyl sulfoxide In dichloromethane at -78℃; for 0.5 h; Inert atmosphere Stage #2: With triethylamine In dichloromethane at -78 - 20℃; for 16 h; Inert atmosphere |
A solution of anhydrous DMSO (5.1mL, 73mmol, 3.0equiv) in anhydrous dichloromethane (50mL) was cooled to −78°C in a dry ice/i-PrOH bath. Oxalyl chloride (6.4mL, 73mmol, 3.0equiv) was added dropwise over 45min. The mixture was stirred for 15min and a solution of 4-bromo-2-methoxybenzyl alcohol (30b; 5.30g, 24mmol) in dichloromethane (10mL) was added dropwise. The resulting mixture was stirred for 30min at −78°C. Triethylamine (12.4g, 120mmol, 5.0equiv) was then added, and the mixture was allowed to warm to rt over 16h. The mixture was quenched with water (100mL) and extracted with chloroform (3×200mL). The combined organic extracts were washed with water (1×150mL), brine (1×150mL), dried (MgSO4), filtered, and evaporated to yield the crude product as dark residue. The residue was purified by flash chromatography using chloroform to obtain an off-white solid that was recrystallized from hexanes to yield 3.73g (71percent) of the product as a white solid: Rf 0.18 (5percent EtOAc/hexane); mp 65–67°C; 1H NMR (CDCl3) δ 10.39 (s, 1H), 7.68 (d, 1H), 7.2–7.16 (m, 2H), 3.94 (s, 3H). |
[ 14804-31-0 ]
4-Bromo-1-methoxy-2-methylbenzene
Similarity: 0.93
[ 170434-11-4 ]
5-Bromo-2-(hydroxymethyl)phenol
Similarity: 0.90
[ 6793-92-6 ]
1-Bromo-4-(phenylmethoxy)benzene
Similarity: 0.89
[ 29578-83-4 ]
1-Bromo-3-methoxy-5-methylbenzene
Similarity: 0.89
[ 14804-31-0 ]
4-Bromo-1-methoxy-2-methylbenzene
Similarity: 0.93
[ 170434-11-4 ]
5-Bromo-2-(hydroxymethyl)phenol
Similarity: 0.90
[ 6793-92-6 ]
1-Bromo-4-(phenylmethoxy)benzene
Similarity: 0.89
[ 29578-83-4 ]
1-Bromo-3-methoxy-5-methylbenzene
Similarity: 0.89
[ 14804-31-0 ]
4-Bromo-1-methoxy-2-methylbenzene
Similarity: 0.93
[ 6793-92-6 ]
1-Bromo-4-(phenylmethoxy)benzene
Similarity: 0.89
[ 36942-56-0 ]
2-Bromo-4-methoxy-1-methylbenzene
Similarity: 0.89
[ 29578-83-4 ]
1-Bromo-3-methoxy-5-methylbenzene
Similarity: 0.89
[ 170434-11-4 ]
5-Bromo-2-(hydroxymethyl)phenol
Similarity: 0.90
[ 2316-64-5 ]
4-Bromo-2-(hydroxymethyl)phenol
Similarity: 0.88
[ 150192-39-5 ]
(2-Bromo-5-methoxyphenyl)methanol
Similarity: 0.87
[ 17100-64-0 ]
(4-Bromo-3-methoxyphenyl)methanol
Similarity: 0.87
[ 38493-59-3 ]
(3-Bromo-4-methoxyphenyl)methanol
Similarity: 0.87